![Analysts: Galera Has Novel Pipeline For Radiation Oncology Market, Commercialization Remains Headwind Analysts: Galera Has Novel Pipeline For Radiation Oncology Market, Commercialization Remains Headwind](https://s.yimg.com/ny/api/res/1.2/6TSnVQCQ1_fqu.u0u3aCUA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNw--/https://cdn1.benzinga.com/files/imagecache/600x400xUP/images/story/2012/hospital-3089884_1920_24.jpg)
Analysts: Galera Has Novel Pipeline For Radiation Oncology Market, Commercialization Remains Headwind
Galera Therapeutics, Inc. Approves Reduction in the Company's Current Workforce by 22 Employees, or Approximately 70% of the Company's Headcount -August 10, 2023 at 08:01 am EDT | MarketScreener
![January 16, 2023, Brazil. in this Photo Illustration, the Galera Therapeutics, Inc Editorial Photo - Image of financial, online: 266588126 January 16, 2023, Brazil. in this Photo Illustration, the Galera Therapeutics, Inc Editorial Photo - Image of financial, online: 266588126](https://thumbs.dreamstime.com/z/january-brazil-photo-illustration-galera-therapeutics-inc-logo-displayed-smartphone-screen-266588126.jpg)
January 16, 2023, Brazil. in this Photo Illustration, the Galera Therapeutics, Inc Editorial Photo - Image of financial, online: 266588126
![In this photo illustration, the Galera Therapeutics, Inc. logo is displayed on a smartphone screen. (Photo by Rafael Henrique / SOPA Images/Sipa USA Stock Photo - Alamy In this photo illustration, the Galera Therapeutics, Inc. logo is displayed on a smartphone screen. (Photo by Rafael Henrique / SOPA Images/Sipa USA Stock Photo - Alamy](https://c8.alamy.com/comp/2M91AXM/brazil-16th-jan-2023-in-this-photo-illustration-the-galera-therapeutics-inc-logo-is-displayed-on-a-smartphone-screen-photo-by-rafael-henriquesopa-imagessipa-usa-credit-sipa-usaalamy-live-news-2M91AXM.jpg)
In this photo illustration, the Galera Therapeutics, Inc. logo is displayed on a smartphone screen. (Photo by Rafael Henrique / SOPA Images/Sipa USA Stock Photo - Alamy
Galera Therapeutics Stock Surges After Its Lead Candidate Shows Median OS Of 20 Months In Pancreatic Cancer Study
![GRTX - Galera Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGM) GRTX - Galera Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGM)](https://images.fintel.io/us-grtx-so.png)